Bladder Carcinoma
Showing 1 - 25 of 29
Bladder Bank (a Prospective Banking Study)
Recruiting
- Bladder Carcinoma
- Hematuria
- Non-Interventional Study
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 25, 2023
Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +18 more
- Clinical Encounter
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jul 24, 2023
Breast Carcinoma, Colorectal Adenocarcinoma, Bladder Carcinoma Trial run by the National Cancer Institute (NCI) (Recombinant
Recruiting
- Breast Carcinoma
- +2 more
- Recombinant human IL-7-hyFc (NT-I7)
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Bladder Carcinoma, Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma Trial in Toronto (biological, procedure,
Recruiting
- Bladder Carcinoma
- +7 more
- Atezolizumab
- +5 more
-
Toronto, Ontario, CanadaUniversity Health Network Princess Margaret Cancer Center LAO
Nov 8, 2022
Advanced Solid Tumor, Head and Neck Squamous Cell Carcinoma, Bladder Carcinoma Trial in Duarte, Iowa City, New York
Recruiting
- Advanced Solid Tumor
- +13 more
- [225Ac]-FPI-1966
- +2 more
-
Duarte, California
- +3 more
Oct 25, 2022
MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)
Active, not recruiting
- MSI-H Colorectal Cancer
- +30 more
-
Badalona, Barcelona, Spain
- +9 more
Oct 24, 2022
ResiduAl Cancer With Liquid Biopsy Evaluation
Recruiting
- Bladder Carcinoma
- +14 more
- Guardant Reveal
-
Redwood City, CaliforniaRedwood City
Sep 7, 2022
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Sexual Function in Women UndergoingRadical Cystectomy for
Recruiting
- Bladder Carcinoma
- Survey Administration
-
Washington, District of Columbia
- +12 more
May 26, 2022
Bladder Carcinoma, Refractory Bladder Carcinoma, Urinary Tract Infection Trial in Buffalo (Clindamycin, Diary, Ertapenem)
Recruiting
- Bladder Carcinoma
- +2 more
- Clindamycin
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 3, 2022
Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus
Active, not recruiting
- Adult Solid Neoplasm
- +16 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Bladder Carcinoma Trial in United States (Laboratory Biomarker Analysis, Nutritional Intervention, Placebo Administration)
Recruiting
- Bladder Carcinoma
- Laboratory Biomarker Analysis
- +4 more
-
Duarte, California
- +46 more
Mar 15, 2022
Lower Urinary Tract Symptoms, Bladder Carcinoma, BCG Trial in Montreal (Pentosan Polysulfate Na 100Mg Cap, Placebo oral capsule)
Terminated
- Lower Urinary Tract Symptoms
- +2 more
- Pentosan Polysulfate Na 100Mg Cap
- Placebo oral capsule
-
Montreal, Quebec, CanadaJewish General Hospital
Feb 16, 2022
Bladder Carcinoma, Breast Carcinoma, Colorectal Carcinoma Trial in Duarte (Communication Intervention, Educational Intervention,
Active, not recruiting
- Bladder Carcinoma
- +5 more
- Communication Intervention
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Bladder Carcinoma, Hernia Trial in Los Angeles (Acellular Cadaveric Dermal Matrix)
Active, not recruiting
- Bladder Carcinoma
- Hernia
- Acellular Cadaveric Dermal Matrix
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Oct 4, 2021
Bladder Carcinoma Trial in Milano (Cabozantinib, Durvalumab)
Unknown status
- Bladder Carcinoma
-
Milano, ItalyFondazione IRCCS Istituto Nazionale Tumori
Feb 24, 2021
Bladder Carcinoma Trial in Seattle (Polyethylene Glycol Hydrogel)
Completed
- Bladder Carcinoma
- Polyethylene Glycol Hydrogel
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 6, 2021
Bladder Carcinoma, Recurrent Bladder Carcinoma Trial in United States (drug, other, procedure)
Terminated
- Bladder Carcinoma
- Recurrent Bladder Carcinoma
- Erlotinib Hydrochloride
- +5 more
-
Baltimore, Maryland
- +5 more
Jun 24, 2020
Transitional Cell Carcinoma, Bladder Carcinoma, Urothelial Carcinoma Trial in United States (Everolimus, Paclitaxel)
Terminated
- Transitional Cell Carcinoma
- +2 more
-
Birmingham, Alabama
- +10 more
Oct 14, 2019
Bladder Carcinoma Trial in Phoenix, Aurora (Intravesical BCG and EMDA/MMC)
Terminated
- Bladder Carcinoma
- Intravesical BCG and EMDA/MMC
-
Phoenix, Arizona
- +1 more
May 24, 2019
Bladder Carcinoma Trial in Seattle (Gabapentin, Placebo, Questionnaire Administration)
Completed
- Bladder Carcinoma
- Gabapentin
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
May 13, 2019
Impaired Cognition, Quality of Life, Surgery Trial in Derby (Exercise Programme)
Completed
- Impaired Cognition
- +9 more
- Exercise Programme
-
Derby, Derbyshire, United KingdomDivision of Graduate Entry Medicine and Health, School of Medici
Apr 16, 2019
Bladder Carcinoma, Post-operative Pain Trial in Los Angeles (Placebo, Questionnaire Administration, Ropivacaine Hydrochloride)
Withdrawn
- Bladder Carcinoma
- Post-operative Pain
- Placebo
- +2 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Apr 13, 2019
Bladder Cancer, Bladder Carcinoma, Transition Cell Cancer Trial in Miami (procedure, radiation, behavioral)
Terminated
- Bladder Cancer
- +3 more
- Transurethral Resection of the Bladder Tumor & Cystoscopy
- +3 more
-
Miami, FloridaUniversity of Miami Sylvester Comprehensive Cancer Center
Aug 3, 2018